THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 151 filers reported holding THERAVANCE INC in Q4 2013. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $530,000 | -94.7% | 37,463 | -93.6% | 0.00% | -96.4% |
| Q3 2014 | $10,060,000 | -25.5% | 588,621 | +29.8% | 0.03% | -22.2% |
| Q2 2014 | $13,506,000 | -3.4% | 453,533 | +0.4% | 0.04% | -14.3% |
| Q1 2014 | $13,980,000 | -13.4% | 451,833 | -0.2% | 0.04% | -12.5% |
| Q4 2013 | $16,136,000 | – | 452,633 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 20,144,301 | $718,144,000 | 20.35% |
| Litespeed Management, L.L.C. | 1,636,994 | $58,359,000 | 8.44% |
| Realm Partners LLC | 240,794 | $8,585,000 | 7.27% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,828,059 | $100,820,000 | 4.97% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,456,503 | $265,824,000 | 3.15% |
| SECTORAL ASSET MANAGEMENT INC | 1,973,188 | $70,344,000 | 3.03% |
| Foundation Asset Management, LP | 221,796 | $7,907,000 | 2.06% |
| Rhenman & Partners Asset Management AB | 132,000 | $4,706,000 | 1.84% |
| BB BIOTECH AG | 888,244 | $31,666,000 | 1.69% |
| HealthCor Management, L.P. | 725,000 | $25,846,000 | 1.57% |